WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Online Marketing Friday, January 18, 2019 
Add Press Release News | News Feeds Feeds | Email This News Email

The Global Nuclear Medicine Market is Expected to Reach $15.2 Billion by 2025, Growing at a CAGR of 10.1% from 2018
Friday, November 09, 2018

DUBLIN, Nov. 9, 2018 /PRNewswire/ --

The "Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Application, By Region (North America, APAC, Europe), And Segment Forecasts, 2018 - 2025" report has been added to's offering.

The global radiopharmaceuticals/nuclear medicine market size is expected to reach USD 15.2 billion by 2025, registering a 10.1% CAGR during the forecast period. The burden of chronic diseases such as cancer and cardiac disorders is on a rise. Nuclear medicine is widely used for diagnosis as well as treatment of such disorders.

Increasing prevalence of these disorders has a direct impact on usage of radiopharmaceuticals. As per data published by the World Health Organization (WHO), cancer is the second leading cause of death around the globe and in 2015, accounted for 8.8 million deaths. This is anticipated to drive demand for radiopharmaceuticals in the years to come.

Diagnostics, when combined with nuclear medicine, improve accuracy to a great extent. This can have a direct impact on decision-making and treatment monitoring processes. Adoption of PET as a diagnostic tool is rapidly increasing since it has shown greater precision over other diagnostic techniques.

Further key findings from the report suggest:

    --  By product, the nuclear medicine market was dominated by the diagnostic
        segment in 2015, driven primarily by advancements in scanning
    --  The therapeutic segment, which comprises alpha emitters, beta emitters,
        and brachytherapy, is anticipated to exhibit lucrative growth over the
        coming years
    --  On the basis of application, diagnostic formed the largest segment in
        2015, including key areas such as cardiology, neurology, oncology, and
    --  North America dominated the global radiopharmaceuticals market in 2015
        owing to well-planned policies, favorable reimbursement structure, high
        healthcare spending, and increasing awareness
    --  Asia Pacific is expected to witness lucrative growth in the coming
        years. Increasing per capita income and reform in policies is attracting
        market players
    --  Key players in the industry include Eckert & Ziegler Group; Mallinckrodt
        Pharmaceuticals; GE Healthcare; Jubilant Life Sciences; Bracco Imaging
        S.p.A; and Nordion, Inc.

Topics Covered

Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Scope And Assumptions
1.3 List Of Abbreviations

Chapter 2 Executive Summary
2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation

Chapter 4 Market Definitions

Chapter 5 Industry Outlook
5.1 Market Variable Analysis
5.1.1 Rising Incidence Of Cancer And Cardiovascular Disease
5.1.2 Widening Applications Of Radiopharmaceuticals
5.1.3 Growing Demand For The Accurate Diagnostic Methods
5.2 Market Restraint Analysis
5.2.1 Stringent Regulation For Production, Storage, And Usage
5.2.2 High Cost Involved With Diagnostics And Therapeutic Procedures

Chapter 6 Business Environment Aanalysis
6.1 SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
6.2 Porter's Five Forces Analysis
6.3 Value Chain Analysis

Chapter 7 Regulatory & Political Forces
7.1 Regulatory Landscape
7.2 Production Process And Trends

Chapter 8 Product Business Analysis
8.1 Radiopharmaceuticals Market: Product Movement Analysis

Chapter 9 Application Mode Business Analysis
9.1 Radiopharmaceuticals Market: Application Movement Analysis.

Chapter 10 Regional Business Analysis
10.1 Radiopharmaceuticals Market: Regional Movement Analysis

Chapter 11 Company Profiles
11.1 Eckert & Ziegler Group
11.2 Mallinckrodt
11.3 GE Healthcare
11.4 Jubilant Life Sciences Ltd.
11.5 Bracco Imaging S.P.A
11.6 Nordion, Inc.
11.7 The Institute For Radioelements (IRE)
11.8 Australian Nuclear Science & Technology Organization (ANSTO)
11.9 NTP Radioisotopes SOC Ltd.
11.10 Eczacibasi - Monrol

Chapter 12 KOL Commentary
12.1 Key Insights
12.2 KOL Views

Chapter 13 Recommendations

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets

Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav transcosmos Expands and Relocates "MC Naha Center," Which Offers Digital Marketing Services | Jan 18, 2019
Nav Real Estate Investor Michael Blank Identifies 3 Stock Market Alternatives for 2019 | Jan 18, 2019
Nav Italy Tire (OEM vs Replacement) Market to 2023 | Jan 17, 2019
Nav Global Retread Tire Market By Vehicle Type (Commercial Vehicle, Passenger Car & OTR Vehicle), By Retread Process (Cold Process & Hot Process), By Region (Asia-Pacific, North America, South America & Others), Competition, Forecast & Opportunities, 2023 | Jan 17, 2019
Nav Welcome Wagon Reviews the State of New Mover Marketing Across the Country | Jan 17, 2019
Nav Gaming Innovation Group Granted Affiliate Vendor Registration in New Jersey | Jan 17, 2019
Nav Third Book in Children's Series Perceives Life Through Pets' Eyes | Jan 17, 2019
Nav Sectra's Capital Markets Day--Focus on Imaging IT Solutions Business Area | Jan 17, 2019
Nav Xulon Press Author Releases Book Journeying Through Bible Covenants | Jan 17, 2019
Nav Stratosphere Networks Sponsors My 65 Benefit for Public Education | Jan 17, 2019

Submit News | View More News View More News